Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomised controlled study
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: ALI, Majid (School of Pharmacy, College Lane Campus, Hatfield, United Kingdom)
- Co-author(s): Schifano, F. (School of Pharmacy, University of Hertfordshire, Hatfield, United Kingdom)
Robinson, P. (Merck Sharp & Dohme Ltd., Hoddesdon, United Kingdom)
Phillips, G. (Manor Pharmacy Group, Hertfordshire, United Kingdom)
Dhillon, S. (School of Pharmacy, University of Hertfordshire, Hatfield, United Kingdom)
Diabetes is one of the leading causes of death and disability worldwide with over 220 million sufferers. Pharmacists have now become more involved in the clinical care of patients, with medication reviews, counselling and more recently as independent prescribers.To develop and implement a pharmaceutical care package for Type 2 diabetes patients..
Meth The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.